Our proprietary synthetic biology technology allows us to virtually activate cellular stress responses, discover drugs targeting stressed cells, and rapidly identify drug targets. We have also developed next-generation deep learning approaches to identifying small molecules that will accelerate our discovery efforts.

Cellular stress responses contribute to diseases including neurodegeneration, cancer, diabetes, osteoarthritis, and other age-associated diseases. Targeting these stress responses with small molecule therapeutics is disease-modifying and will help to mediate healthy aging.